Furthermore, by interacting with RNASET2, PDIA5 can be inactivated, reducing the ability of RNASET2 to produce uracil, and thus improving the cell's ability to capture exogenous uracil and enhancing cancer cell sensitivity to 5-fluorouracil (FU) 18. Here, PDIA5 is linked to cancer.